Triumph Capital Management’s Merck MRK Stock Holding History

Triumph Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$347K	Sell	2,699 -107	-4%	-$12.5K	0.06%	277
2026 Q1	$340K	Sell	2,806 -1,534	-35%	-$177K	0.07%	249
2025 Q4	$457K	Buy	4,340 +768	+22%	+$72.1K	0.1%	186
2025 Q3	$300K	Sell	3,572 -754	-17%	-$62.1K	0.08%	240
2025 Q2	$342K	Buy	4,326 +404	+10%	+$32.1K	0.1%	208
2025 Q1	$352K	Buy	3,922 +403	+11%	+$37.6K	0.12%	190
2024 Q4	$350K	Buy	+3,519	New	+$363K	0.12%	196

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Triumph Capital Management's MRK Position: Q2 2026 in Review

Triumph Capital Management reduced its Merck (MRK) stake by 3.8% in Q2 2026, selling an estimated $12.5K and leaving 2,699 shares worth $347K. The position accounts for 0.06% of the portfolio, ranked #277.

Triumph Capital Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $457K in Q4 2025. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Triumph Capital Management held 2,699 shares of Merck worth $347K as of Q2 2026.
Triumph Capital Management sold 107 Merck shares in Q2 2026, an estimated $12.5K.
Merck made up 0.06% of Triumph Capital Management's portfolio in Q2 2026, its #277 holding.
Triumph Capital Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
Triumph Capital Management's Merck position peaked at $457K in Q4 2025.
1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.